Tag: Multiple Sclerosis
About One in Three Multiple Sclerosis Patients Have Migraine
Pooled prevalence of migraine 31 percent in MS patients, with significant variance internationally
Relapse Rates Lower With Ofatumumab in Multiple Sclerosis
Annualized relapse rates lower for ofatumumab versus teriflunomide in two identical phase 3 trials
Pandemic Causing Increased Anxiety Among MS Patients
Anxiety increased compared with healthy controls and previous patient survey one year before COVID-19
Complementary, Alternative Medicine Use Increasing for MS
Ninefold increase observed in likelihood of patients speaking to their neurologist about CAM use
Progressive MS Linked to Faster Retinal Atrophy Than RRMS
In PMS, inner and outer nuclear layer thinning independently faster compared with controls, RRMS
Older Age, Obesity, Disability Tied to Severe COVID-19 in MS
Proportion of patients with severe COVID-19 higher among those not receiving disease-modifying therapy
Therapeutic Hookworm Explored for Relapsing Multiple Sclerosis
No effect seen for hookworm versus placebo on number of new/enlarging/enhancing lesions
Exposure to Urban Air Pollution May Up Risk of Multiple Sclerosis
Adjusted risk 29 percent higher among those residing in more urbanized areas
Multiple Sclerosis Tied to Higher Risk for CVD, Cerebrovascular Disease
MS associated with a 3.5-fold higher risk for mortality, 1.5-fold higher risk for cardiovascular mortality
Multiple Sclerosis Tied to Higher Risk for CVD, Cerebrovascular Disease
MS associated with a 3.5-fold higher risk for mortality, 1.5-fold higher risk for cardiovascular mortality
